News
Silexion Therapeutics (SLXN) announced compelling preclinical data demonstrating the efficacy of its next-generation RNAi ...
Silexion’s Revolutionary RNAi approach demonstrates powerful anti-tumor activity across three major KRAS-driven cancer types; ...
10d
MedPage Today on MSNCase Study: What's Causing These Osteosclerotic Changes in the Presence of Severe Anemia?As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, or other spine-related symptoms. Lab tests confirmed she had severe anemia; ...
This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...
6dOpinion
Zacks Investment Research on MSN3 Communication Stocks Likely to Surpass Industry ConundrumsHLIT, Ooma, Inc. OOMA and AudioCodes Ltd. AUDC are likely to gain in the long run as demand for scalable infrastructure for ...
6dOpinion
Zacks Investment Research on MSN3 Wireless Non-US Stocks Likely to Thrive on Industry StrengthThe Zacks Wireless Non-US industry appears well-poised to benefit from healthy demand trends stemming from the increasing ...
These achievements will lead to advancements in understanding the mechanism behind β-cell proliferation in order to maintain normal blood glucose levels. In addition, it is anticipated that this ...
Cells are the smallest units of life. But even within the same tissue or organ, they are not all identical. New variations arise continuously during cell proliferation. While genetic mutations alter ...
Life on Earth possesses an exceptional ability to self-reproduce, which, even on a simple cellular level, is driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results